Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

HEMPAVIDA's Hemp CBD + Wellness Launches at Art Basel in Miami, FL

DREAM (Ambien-alternative Sleep Aid), CHILL (Anti-Anxiety), FOCUS (Brain Booster), RESTORE (Joint & Mobility).


News provided by

HEMPAVIDA

Dec 10, 2019, 10:00 ET

Share this article

Share toX

Share this article

Share toX

Wellness by HEMPAVIDA
Wellness by HEMPAVIDA

MIAMI, Dec. 10, 2019 /PRNewswire-PRWeb/ -- HEMPAVIDA, a new innovative wellness and skin care lifestyle brand, launches its first CBD Hemp + Wellness collection at Art Basel in Miami, FL. Amidst a surge of trending hemp CBD products flooding the market, HEMPAVIDA has created a series of "symptom-specific" wellness products blended with other powerful natural ingredients to target ailments such as insomnia, anxiety, stress, mood stability, arthritis, joint mobility, pain, attention, memory, sleeplessness, social angst, and overall well-being.

Wellness by HEMPAVIDA's Hemp CBD interacts with pathways in the body to deliver health benefits, but doesn't bind with receptors in the brain and nervous system, which is why it doesn't cause a psychoactive effect (getting high); unlike marijuana with THC that does in fact cause a "high-effect". There has been increasing demand for pure hemp CBD (without high-effects), for moms who complain of "mommy brain fog", working professions who get random drug tested, college students who don't want to buy something questionable from the campus "dealer", baby boomers who are facing skyrocketing pharma costs, and suburban mainstream who want to try a safe alternative remedy.

It’s not just the mg dosage that makes a hemp CBD-related product effective; blending the right natural ingredients to target specific symptoms is a highly-effective way to dip your toe into the CBD world and ensure you are using it properly to treat your ailments. - Kelly Yocum, CEO HEMPAVIDA

Post this

"It's not just the mg dosage that makes a hemp CBD-related product effective," said Kelly Yocum, CEO HEMPAVIDA "blending the right natural ingredients to target specific symptoms is a highly-effective way to dip your toe into the CBD world and ensure you are using it properly to treat your ailments."

DREAM by HEMPAVIDA is a powerful "Ambien-alternative" natural sleep aid made from a proprietary blend that helps with sleeplessness, insomnia, and correct irregular sleep patterns. DREAM plays a big part in the sleep-wake cycle related to the circadian processes, working naturally to help insomniacs fall into a deep sleep and wake up well rested.

CHILL by HEMPAVIDA is an effective stress-reliever designed to naturally alleviate anxiety, stabilize mood swings, relax social situations, and promote happiness. CHILL is a natural way to relieve tension and give a sense of well-being so users can be more relaxed, positive, an overall better mood without drowsiness or fatigue side-effects.

FOCUS by HEMPAVIDA is a brain booster to help improve cognitive function, memory, focus, clarity, and attention. People are constantly bombarded by information overload finding it hard to stay on track. FOCUS is a natural blend to maintain a healthy brain, be more productive, stay focused and improve memory.

RESTORE by HEMPAVIDA is a blend of potent natural ingredients designed to improve cartilage health by reducing pain, increasing joint mobility, alleviating inflammation, and is used to ease arthritis symptoms.

Consumers nationwide are seeking hemp-based products; however, many hemp CBD supply companies are supplementing with cheap filler ingredients, or just increase the milligram dosage and have had difficulties keeping up with supply and demand. HEMPAVIDA has 3rd party tested, non-GMO, high quality premium hemp extracted using organic farming practices from hemp plants grown on nationally certified farms, and never tests on animals.

HEMPAVIDA is now available on Amazon, and to celebrate the launch of their new products, use 20% off code: CYBER @ http://www.HEMPAVIDA.com.

HEMPAVIDA is in the process of growing its advisory board and executive team as it transitions into its next stage of growth. Request an invitation to one of our investor meetings in Chicago, San Diego, Park City New York, Miami, or San Francisco by contacting [email protected]
Interested in trying HEMPVIDA? Visit HEMPAVIDA.com and sign up for your chance to get a free sample. Be sure to follow @HEMPAVIDA on Facebook, Instagram, and LinkedIn.

ABOUT HEMPAVIDA

HEMPAVIDA is a pure approach to life with clean ingredients from nature. Our products utilize the hemp plant's natural medicinal properties, infused with other elements from nature to provide powerful effective benefits from the inside-out. Interested in being a HEMPAVIDA social media influencer? We are looking for active engaging social media influencers for paid opportunities to help us get the word out. For more information contact: [email protected] 202-360-5470

[Legal Disclaimer: *These products are not intended to diagnose, treat, care, or prevent disease.]

SOURCE HEMPAVIDA

Related Links

http://www.HEMPAVIDA.com

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.